October 2023 La Jolla Psychiatry Conference | HOTEL

ROOM BLOCK SOLD OUT

Estancia La Jolla Hotel & Spa

9700 North Torrey Pines Road
La Jolla, California 92037

Monday, October 9 – Thursday, October 12, 2023

ROOM BLOCK SOLD OUT!
SIGN UP FOR WAITLIST

Our room block for the conference is sold out. There are other hotels in the area that you can book. We have not negotiated any room deals with these hotels and cannot guarantee their rates, availability, parking, or any services they provide. We recommend booking via the hotels direct webpage in case a room opens up at the conference hotel and we can get you in the room block at the contracted group rate. Please make sure to secure accommodations in case a room doesn’t open up. See list of available hotels in the area.

List of La Jolla Area Hotels

FIRST DAY INFORMATION

• Registration from 7:00am-8:00am on Monday, October 9, 2023
• Lectures begin at 8:00am and will conclude approximately at 5:30pm, each day

WHAT’S INCLUDED

If you book using the API Block Code, the room rate includes:

• Discounted resort fee to $20 per day
• Discounted self-parking to $20 per vehicle per day
• 10% discount on Spa Services
• In-room gourmet coffee and tea
• Two bottles of water
• Access to Fitness Center
• Local attraction ticket discounts through the Concierge

Included in the Conference Fee, all participants will receive:

• Coffee/Tea Breaks
• Welcome Reception
• Breakfast and Lunch
• Access to all lectures and activities planned for the meeting

If you have any special physical needs or dietary restrictions that our on-site staff needs to be aware of, please contact Customer Care at 877-225-8384 or email us at support@americanphysician.com.

TAXI AND RIDE-SHARING SERVICES

From San Diego International Airport (SAN)
UberX: $30-$35, one-way
Taxi: $50-$65, one-way
Shuttle Service: The hotel shuttle service is temporarily unavailable. Please contact the concierge if you desire transportation services to and from the hotel.

October 2023 La Jolla Psychiatry Conference | FACULTY

Jack Krasuski, MD

Dr. Krasuski brings a wealth of experience and expertise to the field of psychiatry. He has made significant contributions in both research and academia, establishing himself as a respected professional.

During his tenure as a Senior Staff Fellow at the National Institute on Aging, NIH, Dr. Krasuski conducted groundbreaking research in neuroimaging related to dementing disorders. This experience provided him with valuable insights into the intricate workings of the human brain. Additionally, his role as an Assistant Professor at the University of Illinois Hospital and Clinics further enriched his knowledge and allowed him to contribute to the education and training of future medical professionals.

Dr. Krasuski's exceptional ability to communicate complex concepts with clarity and precision has earned him recognition as a noted educator and speaker. He has a remarkable talent for demystifying difficult and lesser-known topics in psychiatry, ensuring that his audience gains a deep understanding. Currently, he devotes a significant portion of his time to delivering engaging lectures to thousands of physicians annually, sharing his expertise and insights on various psychiatric subjects.

An accomplished professional, Dr. Krasuski has developed over fifty medical education courses each year. This remarkable achievement showcases his commitment to advancing medical knowledge and ensuring that physicians stay informed of the latest developments in their field. Additionally, his extensive experience in business development, entrepreneurship, and public speaking underscores his versatility and expertise beyond the realm of psychiatry.

Dr. Krasuski's contributions extend beyond his clinical and educational endeavors. He has authored publications on psychotherapies, neuropsychological testing, and board exam strategies, further establishing his authority in the field. His dedication to sharing knowledge and promoting excellence in psychiatric care is evident in his ongoing pursuit of innovative approaches and his commitment to professional development.

In summary, Dr. Krasuski is a highly accomplished professional with a profound impact on the field of psychiatry. Through his research, education, and publications, he continues to shape the industry while serving as an inspiring role model for physicians and healthcare professionals alike.

James McCracken, MD

Dr. McCracken is an accomplished and highly respected expert in the field of psychiatry. As the Joseph Campbell Professor of Child Psychiatry and Director of the Division of Child and Adolescent Psychiatry at the UCLA NPI-Semel Institute, he holds a prominent position in the field.

At UCLA, Dr. McCracken leads the National Institute of Mental Health (NIMH) Research Center, "Translational Research to Enhance Cognitive Control." This groundbreaking project focuses on the development and evaluation of innovative treatments for cognitive defects associated with child psychiatric illness. His dedication to improving the lives of children with psychiatric disorders is evident through his research efforts.

In addition to his work on cognitive control, Dr. McCracken is involved in other significant areas of research. He conducts family-genetic studies of childhood disorders, shedding light on the genetic factors influencing these conditions. Moreover, he contributes to the advancement of pharmacologic treatments for various neuropsychiatric disorders in children, including attention-deficit/hyperactivity disorder (ADHD), autism, obsessive-compulsive disorder, and anxiety disorders.

Recognized for his outstanding contributions, Dr. McCracken has received numerous honors and awards throughout his career. Notably, he was the recipient of the American Psychiatric Association (APA) Young Psychiatrist Research Award, underscoring his significant research achievements. With over 150 published papers in the field of child psychiatry, he is a prolific author and an authoritative voice in the academic community.

Mark Frye, MD

Mark A. Frye, MD, is a highly accomplished and dedicated researcher in the fields of genomics, brain imaging, and neuroendocrinology. His clinical interests in bipolar disorder, depression, and alcoholism are closely aligned with his research focus.

Dr. Frye's research endeavors are supported by prestigious institutions, including the National Institute of Mental Health and Mayo Clinic's Samuel C. Johnson Genomics of Addiction Program. He has also received funding from the National Institute on Alcohol Abuse and Alcoholism, as well as contributions from SC Johnson Giving, Inc., the Marriott family, and the Mayo Clinic Center for Individualized Medicine.

One of Dr. Frye's primary areas of investigation is the neurobiology of bipolar disorders. Through the establishment of the Mayo Clinic Individualized Medicine Biobank for Bipolar Disorder, he and his team are diligently working to uncover the underlying mechanisms of these disorders. By utilizing cutting-edge technologies in DNA genomics, mtDNA genomics, proteomics, and epigenomics, they aim to identify key factors contributing to bipolar disorders. Dr. Frye focuses on studying homogeneous subgroups of bipolar disorders through comprehensive and meticulous phenotyping, recognizing the heterogeneity within this diagnostic category.

Dr. Frye's investigations also extend to the psychopharmacology of bipolar disorders. He seeks to identify genetic biomarkers for antidepressant-induced mania, contributing to a better understanding of treatment response and potential side effects. Additionally, he explores the comorbidity of bipolar disorder and alcoholism, investigating metabolite changes in the brains of patients with alcohol disorders before and after treatment with acamprosate, compared to those who did not receive this medication.

Furthermore, Dr. Frye explores acceleration and augmentation strategies in depression. By examining genetic differences between individuals who respond well or poorly to specific medications such as lamotrigine or fluoxetine for bipolar depression, he aims to personalize treatment approaches based on patients' genetic profiles.

Dr. Frye's research has significant implications for patient care. Through genomic studies using the Mayo Clinic Individualized Medicine Biobank for Bipolar Disorder and neuroimaging studies utilizing the Mayo Clinic MRS library, he aims to uncover the underlying mechanisms of bipolar disorder. By discovering proteomic biomarkers, he seeks to develop a validated test for reliable bipolar disorder diagnosis, addressing the current limitations in biological validation of this condition.

Rajkumar Dasgupta, MD

Dr. Raj Dasgupta is a highly accomplished and recognized physician. After completing his residency in Internal Medicine at Michigan State University, he pursued two fellowships: one in Pulmonary & Critical Care at Columbia University, Saint Luke’s & Roosevelt Hospital, and another in Sleep Medicine at Henry Ford Hospital.

Throughout his training, Dr. Dasgupta received numerous prestigious awards, including resident of the year, fellow of the year, and the Director’s Award for research. He subsequently worked at Abington Hospital, affiliated with Jefferson University, where he earned the faculty teacher of the year award.

Currently, Dr. Dasgupta holds the position of Clinical Associate Professor at the University of Southern California (USC). He has consistently received the faculty teaching award for six consecutive years. Additionally, he serves as the Assistant Program Director of Internal Medicine Residency and the Associate Program Director of Sleep Medicine Fellowship at USC.

Dr. Dasgupta holds board certifications in Internal Medicine, Pulmonary, Critical Care, and Sleep Medicine. He is an active clinician and a dedicated clinical researcher. For the past two decades, he has been involved in teaching USMLE Step 1, 2, 3, and Internal Medicine Board Review worldwide.

As an esteemed author, Dr. Dasgupta partnered with Elsevier to publish two book series: "Morning Report: Beyond the Pearls" and "Case Reports: Beyond the Pearls." Beyond his academic pursuits, Dr. Dasgupta is a familiar face in the media. He has made appearances on various platforms and television shows, including Chasing the Cure, The Doctors, CNN, ABC News, and Inside Edition. He also hosts several podcasts, including "The Dr. Raj Podcast," "Beyond the Pearls" medical podcast, and MedPrepToGo. To learn more about Dr. Dasgupta, visit his websites: rajdasgupta.com and beyondthepearls.net.

Sarah Carreira, MD

Dr. Sarah E. Carreira is a dedicated psychiatrist with affiliations at UC San Diego Health-La Jolla and Hillcrest Hospitals. With a medical degree from Michigan State University College of Human Medicine, she brings over 11-20 years of experience to her practice.

Dr. Carreira specializes in psychiatry, focusing on the diagnosis and treatment of mental illnesses. Her expertise encompasses a wide range of conditions, including depression, anxiety disorders, substance abuse, and schizophrenia. She adopts a comprehensive approach to patient care, employing a combination of medications and psychotherapy tailored to each individual's needs.

With a commitment to improving the mental well-being of her patients, Dr. Carreira remains at the forefront of advancements in the field of psychiatry. Through her compassionate and evidence-based approach, she strives to make a positive impact on the lives of those she serves.

Jason Jalil, MD

Dr. Jason Jalil, MD is a highly skilled psychiatrist based in Los Angeles, CA, with over a decade of experience in the medical field. With a strong specialization in Psychotic Disorders, he brings a wealth of expertise to his practice.

Dr. Jalil earned his medical degree from TEL AVIV UNIVERSITY / SACKLER FACULTY OF MEDICINE in 2012, establishing a solid foundation for his career in psychiatry. Throughout his professional journey, he has cultivated extensive knowledge and honed his skills in the diagnosis and treatment of Psychotic Disorders.

Dedicated to providing exceptional care, Dr. Jalil is affiliated with renowned medical facilities, including the Ronald Reagan UCLA Medical Center and UCLA Santa Monica Medical Center. This affiliation ensures that his patients receive access to state-of-the-art resources and comprehensive healthcare services.

Dr. Jalil's practice is open to new patients, and he also offers telehealth appointments, allowing for convenient access to his expertise. He prioritizes patient comfort and convenience, adapting to the evolving landscape of healthcare to provide flexible and accessible care options.

With a compassionate approach and a commitment to personalized treatment, Dr. Jalil strives to improve the mental well-being and quality of life of his patients. His dedication to staying updated with the latest advancements in psychiatric care allows him to provide evidence-based treatment plans tailored to each individual's unique needs.

Margaret Distler, MD, PhD

Dr. Distler is a highly accomplished psychiatrist who plays a vital role in the field of anxiety disorders. With her extensive knowledge and experience, she contributes to the administration of the Anxiety Disorders Clinic and serves as a supervisor for psychiatry residents specializing in cognitive-behavioral therapy (CBT) and medication management.

Dr. Distler's educational background includes an MD and PhD earned from the prestigious University of Chicago. Her doctoral research focused on exploring the genetic and molecular foundations of anxiety, showcasing her commitment to understanding the complex mechanisms underlying this condition.

Following her studies, Dr. Distler completed her psychiatry residency at UCLA, where she held the position of chief resident in the Anxiety Disorders Clinic. During this time, she actively participated in clinical and basic research projects centered around anxiety and depression, contributing to the advancement of knowledge in these areas.

Apart from her involvement in the Anxiety Disorders Clinic, Dr. Distler holds various clinical responsibilities. She provides specialized care to college students with mental illness at UCLA and serves as the Associate Medical Director of the UCLA Aftercare program. In this role, she offers support and treatment to patients experiencing their first episode of schizophrenia.

Dr. Distler's dedication extends to her work at the West Los Angeles Veterans Affairs hospital. There, she contributes to the management of the Anxiety Disorders Clinic, supervises psychiatry residents, and collaborates on the development of residency curricula. Her multifaceted role allows her to make a significant impact on the well-being of patients, while also nurturing the growth and education of future psychiatrists.

With her comprehensive understanding of anxiety disorders, commitment to research, and compassionate patient care, Dr. Distler stands as a respected figure in the psychiatric community. Her efforts in clinical practice, teaching, and research are invaluable contributions that enhance the lives of individuals suffering from mental illness.

Vivien Burt, MD, PhD

Dr. Vivien Burt, M.D., Ph.D., is a distinguished psychiatrist practicing in Los Angeles County, offering tele-psychiatry services via Zoom for the convenience of her patients. With over two decades of experience, she specializes in adult and reproductive psychiatry, making her a trusted expert in women's mental health.

As a Professor of Psychiatry in the esteemed Department of Psychiatry and Biobehavioral Sciences at the David Geffen School of Medicine at UCLA, Dr. Burt is actively involved in academia and research. She is also the Founder and Consultant/Director of The Women's Life Center at the Resnick UCLA Neuropsychiatric Hospital, further exemplifying her dedication to improving the well-being of women.

Dr. Burt's extensive expertise lies in several key areas of specialization. She focuses on reproductive psychiatry and women's mental health, providing comprehensive care to address the unique challenges and psychological needs of women during pregnancy, postpartum, and throughout their reproductive years. Additionally, she offers psychiatric treatment for women transitioning through menopause, recognizing the impact of hormonal changes on mental health and providing support during this stage of life.

Moreover, Dr. Burt specializes in supporting women and couples facing significant life transitions, such as divorce, widowhood, career changes, retirement, or illness. Her compassionate approach assists patients in navigating these challenging periods, promoting emotional well-being and resilience.

In her practice, Dr. Burt also provides general adult psychiatry services to both men and women. She addresses a range of mental health conditions, including depression, bipolar disorder, generalized anxiety disorder, panic disorder, social anxiety disorder, obsessive-compulsive disorder, post-traumatic stress disorder (PTSD), and grief and bereavement.

Dr. Vivien Burt's vast knowledge, compassionate care, and dedication to women's mental health have positioned her as a respected authority in the field. Through her tele-psychiatry services and her roles at UCLA and The Women's Life Center, she continues to make a significant impact on the well-being of her patients, empowering them to lead fulfilling lives.

Mark Townsend, MD, MS

Dr. Mark H. Townsend, M.D., M.S., DLFAPA, FASAM, is a distinguished psychiatrist with a rich academic and clinical background. He completed his undergraduate and graduate studies at the University of Chicago and obtained his M.D. from Tulane University. Dr. Townsend underwent his general psychiatry residency training at the Louisiana State University Health Sciences Center New Orleans, where he excelled as the chief resident. He holds board certifications in both psychiatry and addiction medicine, along with certification in community psychiatry conferred by the American Association of Community Psychiatrists. Currently, he serves as a professor emeritus in the Department of Psychiatry at Louisiana State University Health Sciences Center New Orleans.

Dr. Townsend's expertise spans a range of areas within psychiatry. He has a strong interest in teaching methods and the development of curricula for graduate and medical undergraduate programs. His research focuses on the psychopharmacology of mood and anxiety disorders, as well as exploring the impact of mental illness in marginalized groups, both historically and in contemporary contexts. With a prolific publication record, he has authored numerous manuscripts delving into the effects of medical and psychiatric comorbidities on patient outcomes. Notable topics include the relationship between obsessive-compulsive disorder (OCD) and depression, anxiety disorders and psychosis, and the intersection of heart disease and anxiety.

Recognized as a pioneer in LGBTQ issues within medical education, Dr. Townsend has made significant contributions to the field. His groundbreaking work includes the development of LGBTQ-focused undergraduate medical curricula and the establishment of support services for LGBTQ students themselves. Beyond his scholarly pursuits, Dr. Townsend has an extensive background in clinical practice. He served as the psychiatry medical director for the LSU New Orleans hospitals for a decade following the aftermath of Hurricane Katrina, demonstrating his dedication to providing quality care in challenging circumstances. Moreover, from 2016 to 2022, he held the position of director at the LSU Healthcare Network, further showcasing his leadership and commitment to healthcare excellence.

Kevin Bickart, MD, PhD

Dr. Kevin Bickart, MD, PhD, is an accomplished Assistant Professor in Neurology, specializing in behavioral and sports neurology, as an integral part of UCLA's prestigious BrainSPORT and Neurobehavior programs. His educational journey showcases his dedication to neuroscience and the pursuit of excellence. Dr. Bickart obtained his MD/PhD in anatomy and neurobiology from Boston University School of Medicine, followed by a post-doctoral experience at Northeastern and Harvard Universities. He then completed his residency in neurology at Stanford University, followed by a dual fellowship in behavioral and sports neurology at UCLA.

Throughout his career, Dr. Bickart has made significant contributions to the field. His groundbreaking work includes being the first to identify neuroimaging correlates of social network size in humans, a discovery published in renowned journals such as Nature Neuroscience and The Journal of Neuroscience. Under the guidance of esteemed mentors, including Lisa Feldman Barrett at Northeastern, Brad Dickerson at Harvard, Mike Greicius at Stanford, and more recently Mario Mendez and Chris Giza at UCLA, Dr. Bickart honed his expertise and gained invaluable insights into the intricacies of neuroscience.

Dr. Bickart's research primarily focuses on the intricate brain networks that underlie affective and social behavior, examining their development and deterioration in the context of brain injury and neurodegenerative conditions. His work spans various levels of analysis, encompassing genetics, brain imaging, affective behavior, and real-world social networks. Driven by a passion for innovation, his future endeavors will involve leveraging his expertise in brain mapping and noninvasive neuromodulation to develop personalized treatments for chronic affective and social symptoms associated with traumatic brain injury and frontal lobe dementias.

With his profound knowledge, extensive research contributions, and commitment to advancing the field of neurology, Dr. Kevin Bickart stands as a respected figure in the academic and clinical realms. His dedication to understanding the complexities of the brain and translating that knowledge into effective treatments underscores his role as a valuable asset to UCLA and the broader neuroscience community.

2023 Oasis Mini-Conference Recordings | AGENDA

2023 Oasis Mini-Conference Recordings | FACULTY

Jack Krasuski, MD

Karen Martinez-Gonzalez, MD

Rajkumar Dasgupta, MD

Antonio Hardan, MD

Steven Pliszka, MD

October 2023 La Jolla Psychiatry Conference CME Accreditation

Accreditation Statement:
This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of PeerPoint Medical Education Institute and The American Physician Institute for Advanced Professional Studies, LLC. PeerPoint Medical Education Institute is accredited by the ACCME to sponsor continuing medical education for physicians.

Oasis 2023 Psychiatry Conference – La Jolla, CA Designation Statement:
Live Course, October 9-12, 2023:

The PeerPoint Medical Education Institute, LLC designates this other format activity for a maximum of 52 AMA PRA Category 1 Credits™, (live and enduring material). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Of these 52 credits: 24 are approved for ABPN Self Assessment credits.

This CME activity was planned and produced in accordance with the ACCME Essentials. The American Board of Psychiatry and Neurology has reviewed the Oasis 2023 Psychiatry Conference – La Jolla, CA and has approved this program as a part of a comprehensive Self-Assessment Program, which is mandated by the ABMS as a necessary component of Maintenance of Certification.

Oasis 2022 Psychiatry Conference:

The PeerPoint Medical Education Institute, LLC designates this live and enduring activity for a maximum of 34 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity includes 12 ABPN SA credits.

The American Board of Psychiatry and Neurology has reviewed Oasis 2022 Psychiatry Conference and has approved this program as a part of a comprehensive Self-Assessment Program, which is mandated by the ABMS as a necessary component of Maintenance of Certification.

Oasis 2023 Mini-Conference Designation Statement:
Online Course, Release Date January 28, 2023 Termination Date, January 28, 2026:
The PeerPoint Medical Education Institute, LLC designates the live and enduring formats for this educational activity for a maximum of 8 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses & Nurse Practitioners:
For all your CE requirements for recertification, the ANCC will accept AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.

Physician Assistants:
The NCCPA accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.

Licensed Psychologists:
Most state boards will accept AMA PRA Category 1 Credits™ toward professional development hours. Please confirm with your state board before using this product for professional development hours.

2022 Psychiatry Conference Recordings | FACULTY

Walter Dunn, MD

• Assistant Clinical Professor, Semel Institute for Neuroscience and Human Behavior, UCLA, Los Angeles, CA
• Director of the Mood Clinic and Interventional Psychiatry Service, Greater Los Angeles VA Medical Center, Los Angeles, CA

Rimal Bera, MD

• Clinical Professor of Psychiatry, Department of Psychiatry, University of California, Irvine, CA

Marc Heiser, MD, PhD

Josh Woolley, MD

• Associate Professor of Psychiatry, University of California, San Francisco

Carla Marienfeld, MD

David Taylor, PhD, MSc, FRPharmS, FRCRPEdin, FRCPsych

• Professor of Psychopharmacology, Kings College London, London, UK
• Director of Pharmacy and Pathology, Maudsley Hospital, London, UK

2023 Oasis Mini-Conference Recordings | FACULTY

Jack Krasuski, MD

Karen Martinez-Gonzalez, MD

Rajkumar Dasgupta, MD

Antonio Hardan, MD

Steven Pliszka, MD

Psychiatry Conference Recordings | ACCREDITATION

Intended Audience:

Adult & Child/Adolescent Psychiatrists, Neurologists, Internists, Pediatric Physicians, Family Physicians, Emergency Physicians

Accreditation Statement:

Oasis 2022 Psychiatry Conference has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of PeerPoint Medical Education Institute and The American Physician Institute for Advanced Professional Studies, LLC. PeerPoint Medical Education Institute is accredited by the ACCME to sponsor continuing medical education for physicians.

Oasis 2022 Psychiatry Conference Designation Statement:

The PeerPoint Medical Education Institute, LLC designates this live and enduring activity for a maximum of 34 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity includes 12 ABPN SA credits.

The American Board of Psychiatry and Neurology has reviewed Oasis 2022 Psychiatry Conference and has approved this program as a part of a comprehensive Self-Assessment Program, which is mandated by the ABMS as a necessary component of Maintenance of Certification.

Oasis 2023 Mini-Conference Designation Statement:
Streaming Live, January 28, 2023:

The PeerPoint Medical Education Institute, LLC designates the live and enduring formats for this educational activity for a maximum of 8 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses & Nurse Practitioners: For all your CE requirements for recertification, the ANCC will accept AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.

Physician Assistants: The NCCPA accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.

Licensed Psychologists: Most state boards will accept AMA PRA Category 1 Credits™ toward professional development hours. Please confirm with your state board before using this product for professional development hours.